88 related articles for article (PubMed ID: 12072393)
1. GH and epidermal growth factor signaling in normal and Laron syndrome fibroblasts.
Silva CM; Kloth MT; Whatmore AJ; Freeth JS; Anderson N; Laughlin KK; Huynh T; Woodall AJ; Clayton PE
Endocrinology; 2002 Jul; 143(7):2610-7. PubMed ID: 12072393
[TBL] [Abstract][Full Text] [Related]
2. Activation of the signal transducers and activators of transcription signaling pathway by growth hormone (GH) in skin fibroblasts from normal and GH binding protein-positive Laron Syndrome children.
Freeth JS; Silva CM; Whatmore AJ; Clayton PE
Endocrinology; 1998 Jan; 139(1):20-8. PubMed ID: 9421393
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone (GH)-stimulated insulin-like growth factor I gene expression is mediated by a tyrosine phosphorylation pathway depending on C-terminal region of human GH receptor in human GH receptor-expressing Ba/F3 cells.
Yoshizato H; Tanaka M; Nakai N; Nakao N; Nakashima K
Endocrinology; 2004 Jan; 145(1):214-20. PubMed ID: 14551225
[TBL] [Abstract][Full Text] [Related]
4. A role for Grb2-associated binder-1 in growth hormone signaling.
Kim SO; Loesch K; Wang X; Jiang J; Mei L; Cunnick JM; Wu J; Frank SJ
Endocrinology; 2002 Dec; 143(12):4856-67. PubMed ID: 12446613
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone-dependent differentiation of 3T3-F442A preadipocytes requires Janus kinase/signal transducer and activator of transcription but not mitogen-activated protein kinase or p70 S6 kinase signaling.
Yarwood SJ; Sale EM; Sale GJ; Houslay MD; Kilgour E; Anderson NG
J Biol Chem; 1999 Mar; 274(13):8662-8. PubMed ID: 10085104
[TBL] [Abstract][Full Text] [Related]
6. Insulin receptor substrate-1-mediated enhancement of growth hormone-induced mitogen-activated protein kinase activation.
Liang L; Jiang J; Frank SJ
Endocrinology; 2000 Sep; 141(9):3328-36. PubMed ID: 10965905
[TBL] [Abstract][Full Text] [Related]
7. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone-mediated janus associated kinase-signal transducers and activators of transcription signaling in the growth hormone-resistant potassium-deficient rat.
Schaefer F; Yoon SA; Nouri P; Tsao T; Tummala P; Deng E; Rabkin R
J Am Soc Nephrol; 2004 Sep; 15(9):2299-306. PubMed ID: 15339979
[TBL] [Abstract][Full Text] [Related]
9. Regulation of signal transducer and activator of transcription (STAT) 5b activation by the temporal pattern of growth hormone stimulation.
Gebert CA; Park SH; Waxman DJ
Mol Endocrinol; 1997 Apr; 11(4):400-14. PubMed ID: 9092792
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton.
Rico-Bautista E; Negrín-Martínez C; Novoa-Mogollón J; Fernández-Perez L; Flores-Morales A
Exp Cell Res; 2004 Mar; 294(1):269-80. PubMed ID: 14980520
[TBL] [Abstract][Full Text] [Related]
11. Dexamethasone-induced antagonism of growth hormone (GH) action by down-regulation of GH binding in 3T3-F442A fibroblasts.
King AP; Carter-Su C
Endocrinology; 1995 Nov; 136(11):4796-803. PubMed ID: 7588209
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
13. Amino acids of the human growth hormone receptor that are required for proliferation and Jak-STAT signaling.
Wang YD; Wood WI
Mol Endocrinol; 1995 Mar; 9(3):303-11. PubMed ID: 7539888
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone-induced alteration in ErbB-2 phosphorylation status in 3T3-F442A fibroblasts.
Kim SO; Houtman JC; Jiang J; Ruppert JM; Bertics PJ; Frank SJ
J Biol Chem; 1999 Dec; 274(50):36015-24. PubMed ID: 10585492
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor participates in growth hormone signaling pathway in cardiac myocytes of neonatal rat.
Yuan G; Gu Y
Chin Med J (Engl); 1999 Jun; 112(6):546-9. PubMed ID: 11601336
[TBL] [Abstract][Full Text] [Related]
16. Short communication: A milk trait-associated polymorphism in the bovine growth hormone receptor gene does not affect receptor signaling.
Zhou Y; Jiang H
J Dairy Sci; 2006 May; 89(5):1761-4. PubMed ID: 16606747
[TBL] [Abstract][Full Text] [Related]
17. Characterization and cloning of STAT5 from IM-9 cells and its activation by growth hormone.
Silva CM; Lu H; Day RN
Mol Endocrinol; 1996 May; 10(5):508-18. PubMed ID: 8732682
[TBL] [Abstract][Full Text] [Related]
18. Stimulation by growth hormone (GH) of GH receptor-associated tyrosine kinase activity.
Stred SE; Stubbart JR; Argetsinger LS; Smith WC; Shafer JA; Talamantes F; Carter-Su C
Endocrinology; 1992 Mar; 130(3):1626-36. PubMed ID: 1537311
[TBL] [Abstract][Full Text] [Related]
19. Regulation of JAK2 protein expression by chronic, pulsatile GH administration in vivo: a possible mechanism for ligand enhancement of signal transduction.
Zhou Y; Wang X; Hadley J; Corey SJ; Vasilatos-Younken R
Gen Comp Endocrinol; 2005 Nov; 144(2):128-39. PubMed ID: 15993410
[TBL] [Abstract][Full Text] [Related]
20. Human skin fibroblasts as a model of growth hormone (GH) action in GH receptor-positive Laron's syndrome.
Freeth JS; Ayling RM; Whatmore AJ; Towner P; Price DA; Norman MR; Clayton PE
Endocrinology; 1997 Jan; 138(1):55-61. PubMed ID: 8977385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
